ROYCE & ASSOCIATES LP

Holdings History for Cytek Biosciences, Inc. - Common Stock - $0.001 par value (CTKB)

Symbol: CTKB on Nasdaq
Investment type: Equity / Common Stock - $0.001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.09%	-0%	$8,547,918	1,692,657	-70,605	-4%	$5.05	Q4 2025
30 Sep 2025	0.06%	+0.01%	$6,118,519	1,763,262	+373,456	+27%	$3.47	Q3 2025
30 Jun 2025	0.05%	+0.03%	$4,725,340	1,389,806	+823,987	+146%	$3.40	Q2 2025
31 Mar 2025	0.02%	+0%	$2,268,934	565,819	+95,000		$4.01	Q1 2025
31 Dec 2024	0.03%	+0.02%	$3,055,615	470,819	+289,425	+160%	$6.49	Q4 2024
30 Sep 2024	0.01%	+0%	$1,004,923	181,394	+61,916	+52%	$5.54	Q3 2024
30 Jun 2024	0.01%	+0.01%	$666,687	119,478	+108,128	+953%	$5.58	Q2 2024
31 Mar 2024	0%	+0%	$76,159	11,350	+11,350	NEW	$6.71	Q1 2024
31 Dec 2023		-0%	$0	0	-87,489	-100%	$4.93	Q4 2023
30 Sep 2023	0%	+0%	$482,939	87,489	+15,209	+21%	$5.52	Q3 2023
30 Jun 2023	0.01%	+0%	$617,271	72,280	+27,866	+63%	$8.54	Q2 2023
31 Mar 2023	0%	+0%	$408,165	44,414	+44,414	NEW	$9.19	Q1 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.